Quantitative p53 immunostaining aids in the detection of prevalent dysplasia.
Vikram DeshpandeSteffen RickeltOmer H YilmazPaige H ParrackChenyue LuOsman YilmazElizabeth Y WuWon-Tak ChoiManish GalaDavid T TingRobert D OdzeDeepa T PatilVikram DeshpandePublished in: Journal of clinical pathology (2023)
Automated p53 analysis in NDBE biopsies serves as a promising tool for assessing BE neoplastic progression and risk stratification. Our study highlights the practical applicability of p53 assay to routine surveillance practice and its ability to detect prevalent dysplasia.